The diagnosis from the pathological viewpoint of a blood disease Masafumi Ito Hematomorphology Pages: 2 - 5
The role of morphology, cytochemistry and immunohistochemistry in the diagnosis of chronic myeloproliferative diseases Chin-Yang Li Hematomorphology Pages: 6 - 8
The role of morphology, cytochemistry and immunohistochemistry in the diagnosis of lymphoproliferative disorders Hyun-Sook Chi Hematomorphology Pages: 9 - 10
Mini-transplantation strategy for solid tumors Yoichi Takaue Stem Cell Transplantation Pages: 13 - 14
Chronic graft-versus-host disease and late effects after hematopoietic stem cell transplantation Jean E. Sanders Stem Cell Transplantation Pages: 15 - 28
Allogeneic hemopoietic stem cell transplantation in patients with myelodysplastic syndrome or myelofibrosis H. Joachim DeegPhilippe Guardiola Stem Cell Transplantation Pages: 29 - 34
Targeted gene disruption of natural anticoagulant proteins in mice Tetsuhito Kojima Update on Hypercoagulability Pages: 36 - 39
Effects of hormone replacement therapy on coagulation and fibrinolysis in postmenopausal women Kwang Kon Koh Update on Hypercoagulability Pages: 44 - 46
Recent advances in the diagnosis of antiphospholipid syndrome Hyun-Sook Chi Update on Hypercoagulability Pages: 47 - 51
Monitoring the course of chronic myelogenous leukemia by fluorescencein Situ hybridization Chu-Myong Seong Cytogenetics Pages: 53 - 57
Integrating cytogenetics and gene expression profiling in the molecular analysis of Multiple Myeloma John D. ShaughnessyBart Barlogie Cytogenetics Pages: 59 - 64
Cytogenetic and FISH studies in myelodysplasia, acute myeloid leukemia, chronic lymphocytic leukemia and lymphoma Gordon Dewald W. Cytogenetics Pages: 65 - 74
Pediatric apheresis: Special emphasis on peripheral blood progenitor cell harvest in children Haewon C. Kim Recent Advances in Apheresis Pages: 76 - 76
The eight-year experience of plasmapheresis in patients with neurological diseases Hou-Chang ChiuJiann-Horng YehWei-Hung Chen Recent Advances in Apheresis Pages: 81 - 81
Thalassemia and abnormal hemoglobin Suthat FucharoenPranee Winichagoon Thalassemia and Hemoglobinopathy Pages: 83 - 89
Thalassemia mutations and their clinical aspects in Japan Yukio Hattori Thalassemia and Hemoglobinopathy Pages: 90 - 92
β-Thalassemia in the Korean population Sung Sup ParkHan-Ik Cho Thalassemia and Hemoglobinopathy Pages: 93 - 95
β-Thalassaemia prototype of a single gene disorder with multiple phenotypes Swee Lay Thein Thalassemia and Hemoglobinopathy Pages: 96 - 104
Carrier screening and genetic counselling in β-thalassemia Antonio Cao Thalassemia and Hemoglobinopathy Pages: 105 - 113
High dose chemotherapy and autologous transplantation for non-Hodgkin’s lymphoma Julie M. Vose Malignant Lymphoma Pages: 115 - 115
Idiopathic thrombocytopenic purpura: Pathophysiology and management Yeon S. AhnLawrence L Horstman Update on Bleeding Disorders Pages: 123 - 131
Deficiency of ADAMTS13 in thrombotic thrombocytopenic purpura Han-Mou Tsai Update on Bleeding Disorders Pages: 132 - 138
Management of bleeding disorders by prohemostatic therapy Marcel M. LeviRoel VinkEvert de Jonge Update on Bleeding Disorders Pages: 139 - 144
Molecular diagosis of von Willebrand disease Changgeng Ruan Update on Bleeding Disorders Pages: 145 - 148
Current and emerging technology for HLA typing Derek Middleton Histocompatibility in Field of Hematology Pages: 150 - 151
HLA diversity: Detection and impact on unrelated hematopoietic stem cell · donor characterization and selection Carolyn Katovich Hurley Histocompatibility in Field of Hematology Pages: 152 - 154
Minor histocompatibility antigens-targets of graft versus leukemia responses Stanley R. RiddellM. MurataE. H. Warren Histocompatibility in Field of Hematology Pages: 155 - 161
Views on the pathophysiology of aplastic anaemia Edward C. Gordon-SmithJ. C. MarshF. M. Gibson Understanding and Treatment of Acquired Aplastic Anemia Pages: 163 - 166
New advances in the treatment of acquired severe aplastic anaemia Jill Hows Understanding and Treatment of Acquired Aplastic Anemia Pages: 167 - 167
The relationship of aplastic anemia and PNH Neal S. YoungJaroslaw P. MaciejewskiAkira Miyazato Understanding and Treatment of Acquired Aplastic Anemia Pages: 168 - 172
Aplastic anemia in the orient Seiji Kojima Understanding and Treatment of Acquired Aplastic Anemia Pages: 173 - 174
Clinical importance of genetic findings in adult AML Clara D. Bloomfield The Biology and Treatment of Acute Myeloid Leukemia Pages: 176 - 177
Biologically risk directed therapy for improved trial development and outcomes in patients with AML Robert J. Arceci The Biology and Treatment of Acute Myeloid Leukemia Pages: 178 - 178
New advances in the treatment of acute promyelocytic leukemia Dan Douer The Biology and Treatment of Acute Myeloid Leukemia Pages: 179 - 187
Treatment of chronic myeloid leukaemia lessons and challenges John M. Goldman Chronic Leukemia Pages: 189 - 192
Clinical and scientific advances in the philadelphia-chromosome negative chronic myeloproliferative disorders Ruben A. Mesa Chronic Leukemia Pages: 193 - 203
Real-time PCR for monitoring minimal residual disease and chimerism in patients after allogeneic transplantation Ahmet H. Elmaagacli Chronic Leukemia Pages: 204 - 205
Biology and modulation of multidrug resistance (MDR) in hematological malignancies Masao Hirose Chronic Leukemia Pages: 206 - 211
Important features of myelodysplastic syndrome Wolf-K. HofmannH. Phillip Koeffler Myelodysplastic Syndrome Pages: 222 - 227
The Myelodysplastic Syndromes: Morphology, risk assessment, and clinical management (2002) John M. BennettPeter A. KouidesStephen J. Forman Myelodysplastic Syndrome Pages: 228 - 238
Human T lymphotropic virus type-I and adult T-cell leukemia in Japan Kazunari YamaguchiToshiki Watanabe Safety Issues in Blood & Blood Products Transfusion Pages: 240 - 245
Human herpesvirus 6 and human herpesvirus 7: Emerging pathogens in transplant patients Duncan A. Clark Safety Issues in Blood & Blood Products Transfusion Pages: 246 - 252
Pathogen inactivation of blood components: Current status and introduction of an approach using riboflavin as a photosensitizer Frank Corbin Safety Issues in Blood & Blood Products Transfusion Pages: 253 - 257
